Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

AffronEYE Easy On The Eyes For Gamers

In a digital-world Pharmactive's affronEYE® saffron extract could help reduce the risks of long-term blue-light induced eye injury


News provided by

Pharmactive Biotech Products, S.L.

Jul 21, 2020, 07:00 ET

Share this article

Share toX

Share this article

Share toX

MADRID, July 21, 2020 /PRNewswire/ -- In a digital era, the increasing dependence on screens and technology particularly among gamers is prolonging exposure to blue light. Madrid-based nutraceutical experts Pharmactive Biotech Products S.L.'s offers its proprietary affronEYE® saffron ingredient, a fast-absorbing antioxidant that can potentially address the negative impacts of blue-light exposure including Gamer Eye Syndrome and provide overall support to eye health.

A Digital Vision Syndrome Epidemic

Continue Reading
AffronEYE Easy On The Eyes For Gamers
AffronEYE Easy On The Eyes For Gamers

A monotonous straight view during long sessions in front of a computer screen can result in reduced eye blinking, inevitably resulting in irritated or inflamed eyes. This is especially common after continuous long periods of gaming or as a result of daily office work. The condition has many names: Gamer Eye Syndrome, Computer Vision Syndrome, Digital Vision Syndrome. Symptoms of Gamer Eye Syndrome includes: Eyestrain, itchy and burning eyes, redness of the eyes, extremely dry eyes, nausea, malaise, visual defects, headaches, and neck and shoulder pain.[1]

Screen consumption is particularly elevated in younger age groups with a growing number of avid e-gamers and e-sports enthusiasts. Screen time spiked to more than 13 hours per day during the pandemic, according to Eyesafe Nielsen[2] estimates. Parents are concerned this may be having long-term repercussions on their children's eye health.

"Limiting screen-time is definitely the best solution, but with in-person socializing having practically disappeared, and more people working from home and gaming on the increase, reducing screen time might not be practical," says Julia Diaz, Head of Marketing for Pharmactive. "AffronEYE is a next-gen ingredient formulated specifically to address eye health, also from blue-light strain."

Consumers increasingly are seeking safe, natural aids that can proactively safeguard their eyes from digital injury. According to Market Watch data, the global eye health supplements Market is expected grow at CAGR of 6.2% by 2024 reaching a global value of $US2.85 Billion.[3]

Studies[4] have shown that short-wavelength blue visible light induces photo-oxidative stress, retinal injury and may be a risk factor for developing macular degeneration and other eye related diseases such a glaucoma later on down the road A recent epidemiological study reveals a rising prevalence of early onset myopia among school children globally with highest prevalence in Asia (60%) compared to Europe (40%). This raises the risks of progression to myopic macular degeneration, retinal detachment, and other eye pathologies.[5]

Saffron extract may ease the strain on blue-light stricken eyes

AffronEYE is derived of all natural extraction of 100 % Spanish saffron (Crocus sativus L.). The formula is standardized to 3% crocins. Crocins are the major carotenoids of saffron, which act as potent antioxidants. Pharmactive's advanced organic formulation ensures that these compounds are rapidly absorbed and can reach the maximum concentration in blood after only 1.5 hours — significantly faster than other traditional carotenoids used for eye health, such as lutein, zeaxanthin, and β-carotene.

"Major eye disorders, regardless of their cause, involve the activation of oxidative stress, as well as chronic inflammation which are key drivers to develop a wide range of ocular diseases. Oxidative stress occurs as a result of the disruption of the balance between the antioxidant system and the pro-oxidant system found in cells. When this balance is altered, oxidants or more specifically Reactive Oxygen Species damage the cells and the tissues," says Alberto Espinel, Manager of Strategic R&D in Active and Functional Natural Ingredients for Pharmactive.

Various studies suggest that saffron supplementation, such as with affronEYE, improves visual function, preserving retina's photoreceptors function and retinal flicker sensitivity. A recent clinical study by Pharmactive demonstrated affronEYE's ability to preserve the retinal functional integrity after a provoked serious insult in experimental tests conditions.[6]

"AffronEYE's unique composition of naturally occurring carotenoids contains a synergistic spectrum of anti-inflammatory, antioxidative, and neuroprotective properties with abilities to scavenge free oxygen radicals. This reduces retinal cell damage and cellular self-destruction which could be of particular relevance as an effective preventative measure," adds Diaz.

Affron®EYE is water-soluble and suitable for food matrices, beverage powders, supplements, dairy foods, and more. It is non-GMO, non-irradiated, and carries both kosher and halal certifications.

1. https://www.gamingchairz.com/gamer-eye-syndrome-health-problems-caused-by-video-games/
2. https://eyesafe.com/covid-19-screen-time-spike-to-over-13-hours-per-day/
3. http://www.molvis.org/molvis/v22/61/
4. Romero F.J., et al. 1998. Environ Health Perspect. 106(Suppl 5): 1229–1234; 33(4): 399–417; (2) María Dolores Pinazo-Durán. Clin Interv Aging. 2014; 9: 637–652.
5. https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-019-1220-0
6. Fernández-Albarral JA., et al. 2019. Int J Mol Sci. 2019 Sep; 20(17): 4110

Photo - https://mma.prnewswire.com/media/1217300/Pharmactive_affronEYE_Gamers.jpg

For more information, contact:

Company contact:
Pharmactive Biotech Products, S.L.
Julia Diaz, Head of Marketing
Tel: +34 91 112 38 48
Email: [email protected]
Twitter: @Pharmactive_SP
Web: www.pharmactive.eu

Press Contact:
NutriPR
Liat Simha
Tel: +972-9-9742893
E-mail: [email protected]
Twitter: @NutriPR_
Website: www.nutripr.com

SOURCE Pharmactive Biotech Products, S.L.

Related Links

http://pharmactive.eu

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.